[
  {
    "ts": null,
    "headline": "Danaher price target lowered to $240 from $260 at Goldman Sachs",
    "summary": "Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Danaher (DHR) to $240 from $260 but keeps a Buy rating on the shares after its Q1 results. The company’s Bioprocessing business continues to improve, and the current tariff headwind appears manageable, the analyst tells investors in a research note. Despite the top and bottom line beat in the quarter however, there is still merit in the prudent approach with Danaher maintaining prior FY25 guidance given all the moving parts a",
    "url": "https://finnhub.io/api/news?id=87c25cc07bc9d177edcaf74575f7c9dba24a3740f4386747fb3eb98a3c621b42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745443848,
      "headline": "Danaher price target lowered to $240 from $260 at Goldman Sachs",
      "id": 134059589,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Danaher (DHR) to $240 from $260 but keeps a Buy rating on the shares after its Q1 results. The company’s Bioprocessing business continues to improve, and the current tariff headwind appears manageable, the analyst tells investors in a research note. Despite the top and bottom line beat in the quarter however, there is still merit in the prudent approach with Danaher maintaining prior FY25 guidance given all the moving parts a",
      "url": "https://finnhub.io/api/news?id=87c25cc07bc9d177edcaf74575f7c9dba24a3740f4386747fb3eb98a3c621b42"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corp. stock outperforms competitors on strong trading day",
    "summary": "Danaher Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=3ac145d1e6f0d220032a3f185b68f5ad97987ae63c1e885ded21522cf4a4fe2a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745426100,
      "headline": "Danaher Corp. stock outperforms competitors on strong trading day",
      "id": 134055575,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Danaher Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=3ac145d1e6f0d220032a3f185b68f5ad97987ae63c1e885ded21522cf4a4fe2a"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corporation (DHR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential",
    "summary": "We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other top stocks in Bill Gates’ portfolio with huge upside potential. Bill Gates became the youngest billionaire back in 1987 when he took […]",
    "url": "https://finnhub.io/api/news?id=fc686e3b1455ad7c977aca34dd065bae7205414884d60e6a9164ddc4958cbd63",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745424619,
      "headline": "Danaher Corporation (DHR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential",
      "id": 134046600,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other top stocks in Bill Gates’ portfolio with huge upside potential. Bill Gates became the youngest billionaire back in 1987 when he took […]",
      "url": "https://finnhub.io/api/news?id=fc686e3b1455ad7c977aca34dd065bae7205414884d60e6a9164ddc4958cbd63"
    }
  },
  {
    "ts": null,
    "headline": "BLCO or DHR: Which Is the Better Value Stock Right Now?",
    "summary": "BLCO vs. DHR: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=c831a1a4ce1bc7b41b28fe432df9097a345cdcd340ce3b9e7792c3c9150d3952",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745422807,
      "headline": "BLCO or DHR: Which Is the Better Value Stock Right Now?",
      "id": 134046601,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "BLCO vs. DHR: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=c831a1a4ce1bc7b41b28fe432df9097a345cdcd340ce3b9e7792c3c9150d3952"
    }
  },
  {
    "ts": null,
    "headline": "Danaher First Quarter 2025 Earnings: Beats Expectations",
    "summary": "Danaher ( NYSE:DHR ) First Quarter 2025 Results Key Financial Results Revenue: US$5.74b (flat on 1Q 2024). Net income...",
    "url": "https://finnhub.io/api/news?id=fe881c624d40732193815e7df08211cc3f412795a5215730dbc01e1df34bff8f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745403377,
      "headline": "Danaher First Quarter 2025 Earnings: Beats Expectations",
      "id": 134046602,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher ( NYSE:DHR ) First Quarter 2025 Results Key Financial Results Revenue: US$5.74b (flat on 1Q 2024). Net income...",
      "url": "https://finnhub.io/api/news?id=fe881c624d40732193815e7df08211cc3f412795a5215730dbc01e1df34bff8f"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corp (DHR) Q1 2025 Earnings Call Highlights: Strong Bioprocessing Growth Amidst Mixed ...",
    "summary": "Danaher Corp (DHR) reports robust bioprocessing growth and improved profitability, despite challenges in Life Sciences and Diagnostics segments.",
    "url": "https://finnhub.io/api/news?id=034e26263aa8bde0fa9db81e5ad5dfe4b3a6470664a931c1685c88b59e1f6031",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745391715,
      "headline": "Danaher Corp (DHR) Q1 2025 Earnings Call Highlights: Strong Bioprocessing Growth Amidst Mixed ...",
      "id": 134046603,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Danaher Corp (DHR) reports robust bioprocessing growth and improved profitability, despite challenges in Life Sciences and Diagnostics segments.",
      "url": "https://finnhub.io/api/news?id=034e26263aa8bde0fa9db81e5ad5dfe4b3a6470664a931c1685c88b59e1f6031"
    }
  },
  {
    "ts": null,
    "headline": "Q1 2025 Danaher Corp Earnings Call",
    "summary": "Q1 2025 Danaher Corp Earnings Call",
    "url": "https://finnhub.io/api/news?id=3f616c6ffced17d237bae116a9c0c565a85d68e3cbf94e408cbfd901c5b5341f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745375438,
      "headline": "Q1 2025 Danaher Corp Earnings Call",
      "id": 134039057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Q1 2025 Danaher Corp Earnings Call",
      "url": "https://finnhub.io/api/news?id=3f616c6ffced17d237bae116a9c0c565a85d68e3cbf94e408cbfd901c5b5341f"
    }
  },
  {
    "ts": null,
    "headline": "DHR Q1 Earnings: Bioprocessing Momentum and Tariff Strategy Drive Guidance Above Expectations",
    "summary": "Diversified science and technology company Danaher (NYSE:DHR) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue was better than expected at $5.92 billion at the midpoint, 1.4% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 14.4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=1d188bd5ad6a345aa5fe8289b1204856588825ec8dc9c6ab2688d7e3cffbb1c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745372138,
      "headline": "DHR Q1 Earnings: Bioprocessing Momentum and Tariff Strategy Drive Guidance Above Expectations",
      "id": 134039058,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Diversified science and technology company Danaher (NYSE:DHR) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue was better than expected at $5.92 billion at the midpoint, 1.4% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 14.4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=1d188bd5ad6a345aa5fe8289b1204856588825ec8dc9c6ab2688d7e3cffbb1c6"
    }
  }
]